Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
G275946-5mg | 5mg | In stock | $48.90 | |
G275946-10mg | 10mg | In stock | $69.90 | |
G275946-25mg | 25mg | In stock | $140.90 | |
G275946-50mg | 50mg | In stock | $235.90 | |
G275946-100mg | 100mg | In stock | $400.90 |
Potent and selective, brain penetrant LRRK2 inhibitor.
Synonyms | [4-[[4-(Ethylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2-fluoro-5-methoxyphenyl]-4-morpholinyl-methanone;(4-((4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of leucine rich repeat kinase 2;Inhibitor of TTK protein kinase |
Product Description | Shipped at room temperature. Store at -20°C. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [4-[[4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-2-fluoro-5-methoxyphenyl]-morpholin-4-ylmethanone |
---|---|
INCHI | InChI=1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27) |
InChi Key | XCFLWTZSJYBCPF-UHFFFAOYSA-N |
Canonical SMILES | CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC |
Isomeric SMILES | CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC |
PubChem CID | 58539171 |
Molecular Weight | 443.4 |
CAS Registry No. | 1351761-44-8 |
---|---|
PubChem CID | 58539171 |
ChEMBL Ligand | CHEMBL2178134 |
BindingDB Ligand | 50398668 |
RCSB PDB Ligand | A0T |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2208154 | Certificate of Analysis | Nov 15, 2022 | G275946 |
B2208158 | Certificate of Analysis | Nov 15, 2022 | G275946 |
B2208162 | Certificate of Analysis | Nov 15, 2022 | G275946 |
B2208323 | Certificate of Analysis | Nov 15, 2022 | G275946 |
B2208352 | Certificate of Analysis | Nov 15, 2022 | G275946 |
Solubility | Soluble in DMSO to 50 mM warming |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. |
1. Estrada AA, Liu X, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chan BK, Chen H, Ding X, DiPasquale AG et al.. (2012) Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.. J Med Chem, 55 (22): (9416-33). [PMID:22985112] |
2. Estrada AA, Chan BK, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chen H, Dominguez SL, Dotson J, Drummond J et al.. (2014) Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.. J Med Chem, 57 (3): (921-36). [PMID:24354345] |